Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
57.1M
-
Number of holders
-
170
-
Total 13F shares, excl. options
-
47.8M
-
Shares change
-
+2.02M
-
Total reported value, excl. options
-
$2.32B
-
Value change
-
+$88.9M
-
Put/Call ratio
-
0.1
-
Number of buys
-
95
-
Number of sells
-
-77
-
Price
-
$48.77
Significant Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q2 2022
194 filings reported holding HRMY - Harmony Biosciences Holdings, Inc. - Common Stock as of Q2 2022.
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) has 170 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.8M shares
of 57.1M outstanding shares and own 83.63% of the company stock.
Largest 10 shareholders include Valor Management LLC (11.2M shares), FMR LLC (5.43M shares), Vivo Capital, LLC (4.09M shares), BlackRock Inc. (3.97M shares), VANGUARD GROUP INC (2.96M shares), venBio Partners LLC (1.45M shares), JANUS HENDERSON GROUP PLC (1.43M shares), Blackstone Inc. (1.05M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.03M shares), and STATE STREET CORP (944K shares).
This table shows the top 170 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.